Project
Mucociliary differentiation, bronchial epithelial cells, human (Ross 2007)
Navigation
Downloads
Results for RXRG
Z-value: 1.61
Motif logo
Transcription factors associated with RXRG
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
RXRG
|
ENSG00000143171.8 | retinoid X receptor gamma |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| RXRG | hg19_v2_chr1_-_165414414_165414433 | -0.28 | 1.3e-01 | Click! |
Activity profile of RXRG motif
Sorted Z-values of RXRG motif
| Promoter | Log-likelihood | Transcript | Gene | Gene Info |
|---|---|---|---|---|
| chr19_-_51504852 | 6.68 |
ENST00000391806.2
ENST00000347619.4 ENST00000291726.7 ENST00000320838.5 |
KLK8
|
kallikrein-related peptidase 8 |
| chr10_+_88718397 | 6.18 |
ENST00000372017.3
|
SNCG
|
synuclein, gamma (breast cancer-specific protein 1) |
| chr2_+_234104079 | 5.72 |
ENST00000417661.1
|
INPP5D
|
inositol polyphosphate-5-phosphatase, 145kDa |
| chr10_+_88718314 | 5.71 |
ENST00000348795.4
|
SNCG
|
synuclein, gamma (breast cancer-specific protein 1) |
| chr18_-_21242774 | 4.67 |
ENST00000322980.9
|
ANKRD29
|
ankyrin repeat domain 29 |
| chr1_-_154946825 | 4.42 |
ENST00000368453.4
ENST00000368450.1 ENST00000366442.2 |
SHC1
|
SHC (Src homology 2 domain containing) transforming protein 1 |
| chr12_-_57634475 | 4.20 |
ENST00000393825.1
|
NDUFA4L2
|
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 4-like 2 |
| chr3_-_50340996 | 4.20 |
ENST00000266031.4
ENST00000395143.2 ENST00000457214.2 ENST00000447605.2 ENST00000418723.1 ENST00000395144.2 |
HYAL1
|
hyaluronoglucosaminidase 1 |
| chr7_+_2671663 | 3.72 |
ENST00000407643.1
|
TTYH3
|
tweety family member 3 |
| chr17_+_39969183 | 3.70 |
ENST00000321562.4
|
FKBP10
|
FK506 binding protein 10, 65 kDa |
| chr1_-_153521597 | 3.63 |
ENST00000368712.1
|
S100A3
|
S100 calcium binding protein A3 |
| chr18_-_21242833 | 3.59 |
ENST00000586087.1
ENST00000592179.1 |
ANKRD29
|
ankyrin repeat domain 29 |
| chr5_+_150591678 | 3.51 |
ENST00000523466.1
|
GM2A
|
GM2 ganglioside activator |
| chr22_+_31489344 | 3.50 |
ENST00000404574.1
|
SMTN
|
smoothelin |
| chr16_-_85784557 | 3.50 |
ENST00000602675.1
|
C16orf74
|
chromosome 16 open reading frame 74 |
| chr19_-_1174226 | 3.49 |
ENST00000587024.1
ENST00000361757.3 |
SBNO2
|
strawberry notch homolog 2 (Drosophila) |
| chr16_-_85784634 | 3.28 |
ENST00000284245.4
ENST00000602914.1 |
C16orf74
|
chromosome 16 open reading frame 74 |
| chr1_-_6479963 | 3.26 |
ENST00000377836.4
ENST00000487437.1 ENST00000489730.1 ENST00000377834.4 |
HES2
|
hes family bHLH transcription factor 2 |
| chr11_+_450255 | 3.25 |
ENST00000308020.5
|
PTDSS2
|
phosphatidylserine synthase 2 |
| chr6_+_43737939 | 3.23 |
ENST00000372067.3
|
VEGFA
|
vascular endothelial growth factor A |
| chr19_-_46148820 | 3.22 |
ENST00000587152.1
|
EML2
|
echinoderm microtubule associated protein like 2 |
| chr17_+_7211280 | 3.19 |
ENST00000419711.2
ENST00000571955.1 ENST00000573714.1 |
EIF5A
|
eukaryotic translation initiation factor 5A |
| chr17_+_39975455 | 3.19 |
ENST00000455106.1
|
FKBP10
|
FK506 binding protein 10, 65 kDa |
| chr17_+_39975544 | 3.15 |
ENST00000544340.1
|
FKBP10
|
FK506 binding protein 10, 65 kDa |
| chr17_+_40811283 | 3.11 |
ENST00000251412.7
|
TUBG2
|
tubulin, gamma 2 |
| chr1_-_6420737 | 2.98 |
ENST00000541130.1
ENST00000377845.3 |
ACOT7
|
acyl-CoA thioesterase 7 |
| chr12_-_54813229 | 2.97 |
ENST00000293379.4
|
ITGA5
|
integrin, alpha 5 (fibronectin receptor, alpha polypeptide) |
| chr12_-_51785182 | 2.96 |
ENST00000356317.3
ENST00000603188.1 ENST00000604847.1 ENST00000604506.1 |
GALNT6
|
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 6 (GalNAc-T6) |
| chr1_-_153521714 | 2.87 |
ENST00000368713.3
|
S100A3
|
S100 calcium binding protein A3 |
| chr19_+_676385 | 2.84 |
ENST00000166139.4
|
FSTL3
|
follistatin-like 3 (secreted glycoprotein) |
| chr15_-_75017711 | 2.83 |
ENST00000567032.1
ENST00000564596.1 ENST00000566503.1 ENST00000395049.4 ENST00000395048.2 ENST00000379727.3 |
CYP1A1
|
cytochrome P450, family 1, subfamily A, polypeptide 1 |
| chr17_+_3627185 | 2.81 |
ENST00000325418.4
|
GSG2
|
germ cell associated 2 (haspin) |
| chr7_+_143079000 | 2.79 |
ENST00000392910.2
|
ZYX
|
zyxin |
| chr19_+_926000 | 2.78 |
ENST00000263620.3
|
ARID3A
|
AT rich interactive domain 3A (BRIGHT-like) |
| chr9_-_110251836 | 2.77 |
ENST00000374672.4
|
KLF4
|
Kruppel-like factor 4 (gut) |
| chr2_+_27008865 | 2.75 |
ENST00000335756.4
ENST00000233505.8 |
CENPA
|
centromere protein A |
| chr7_-_107643674 | 2.72 |
ENST00000222399.6
|
LAMB1
|
laminin, beta 1 |
| chr15_-_81616446 | 2.71 |
ENST00000302824.6
|
STARD5
|
StAR-related lipid transfer (START) domain containing 5 |
| chrX_+_135229600 | 2.70 |
ENST00000370690.3
|
FHL1
|
four and a half LIM domains 1 |
| chr7_+_116165754 | 2.68 |
ENST00000405348.1
|
CAV1
|
caveolin 1, caveolae protein, 22kDa |
| chr2_-_208031542 | 2.67 |
ENST00000423015.1
|
KLF7
|
Kruppel-like factor 7 (ubiquitous) |
| chr22_+_38035459 | 2.67 |
ENST00000357436.4
|
SH3BP1
|
SH3-domain binding protein 1 |
| chr18_+_56530794 | 2.66 |
ENST00000590285.1
ENST00000586085.1 ENST00000589288.1 |
ZNF532
|
zinc finger protein 532 |
| chr7_+_116166331 | 2.66 |
ENST00000393468.1
ENST00000393467.1 |
CAV1
|
caveolin 1, caveolae protein, 22kDa |
| chr20_+_42295745 | 2.62 |
ENST00000396863.4
ENST00000217026.4 |
MYBL2
|
v-myb avian myeloblastosis viral oncogene homolog-like 2 |
| chr7_+_143078652 | 2.55 |
ENST00000354434.4
ENST00000449423.2 |
ZYX
|
zyxin |
| chr1_-_113498943 | 2.53 |
ENST00000369626.3
|
SLC16A1
|
solute carrier family 16 (monocarboxylate transporter), member 1 |
| chr1_-_113498616 | 2.49 |
ENST00000433570.4
ENST00000538576.1 ENST00000458229.1 |
SLC16A1
|
solute carrier family 16 (monocarboxylate transporter), member 1 |
| chr16_+_30194916 | 2.47 |
ENST00000570045.1
ENST00000565497.1 ENST00000570244.1 |
CORO1A
|
coronin, actin binding protein, 1A |
| chrX_+_135229731 | 2.47 |
ENST00000420362.1
|
FHL1
|
four and a half LIM domains 1 |
| chr20_-_56285595 | 2.47 |
ENST00000395816.3
ENST00000347215.4 |
PMEPA1
|
prostate transmembrane protein, androgen induced 1 |
| chrX_+_135229559 | 2.45 |
ENST00000394155.2
|
FHL1
|
four and a half LIM domains 1 |
| chr12_-_52585765 | 2.43 |
ENST00000313234.5
ENST00000394815.2 |
KRT80
|
keratin 80 |
| chr11_-_59436453 | 2.36 |
ENST00000300146.9
|
PATL1
|
protein associated with topoisomerase II homolog 1 (yeast) |
| chr1_+_230202936 | 2.36 |
ENST00000366672.4
|
GALNT2
|
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 2 (GalNAc-T2) |
| chr5_-_131562935 | 2.35 |
ENST00000379104.2
ENST00000379100.2 ENST00000428369.1 |
P4HA2
|
prolyl 4-hydroxylase, alpha polypeptide II |
| chr14_+_75745477 | 2.34 |
ENST00000303562.4
ENST00000554617.1 ENST00000554212.1 ENST00000535987.1 ENST00000555242.1 |
FOS
|
FBJ murine osteosarcoma viral oncogene homolog |
| chr13_+_96204961 | 2.34 |
ENST00000299339.2
|
CLDN10
|
claudin 10 |
| chr17_+_7210898 | 2.29 |
ENST00000572815.1
|
EIF5A
|
eukaryotic translation initiation factor 5A |
| chrX_-_49042778 | 2.28 |
ENST00000538114.1
ENST00000376310.3 ENST00000376317.3 ENST00000417014.1 |
PRICKLE3
|
prickle homolog 3 (Drosophila) |
| chr17_-_40575535 | 2.28 |
ENST00000357037.5
|
PTRF
|
polymerase I and transcript release factor |
| chr11_-_119599794 | 2.27 |
ENST00000264025.3
|
PVRL1
|
poliovirus receptor-related 1 (herpesvirus entry mediator C) |
| chr6_+_32121908 | 2.20 |
ENST00000375143.2
ENST00000424499.1 |
PPT2
|
palmitoyl-protein thioesterase 2 |
| chr1_+_153750622 | 2.19 |
ENST00000532853.1
|
SLC27A3
|
solute carrier family 27 (fatty acid transporter), member 3 |
| chr6_+_32121789 | 2.17 |
ENST00000437001.2
ENST00000375137.2 |
PPT2
|
palmitoyl-protein thioesterase 2 |
| chr5_-_149682447 | 2.15 |
ENST00000328668.7
|
ARSI
|
arylsulfatase family, member I |
| chrX_+_153686614 | 2.15 |
ENST00000369682.3
|
PLXNA3
|
plexin A3 |
| chr9_-_35103105 | 2.10 |
ENST00000452248.2
ENST00000356493.5 |
STOML2
|
stomatin (EPB72)-like 2 |
| chr1_-_150693318 | 2.06 |
ENST00000442853.1
ENST00000368995.4 ENST00000368993.2 ENST00000361824.2 ENST00000322343.7 |
HORMAD1
|
HORMA domain containing 1 |
| chr19_+_6361795 | 2.05 |
ENST00000596149.1
|
CLPP
|
caseinolytic mitochondrial matrix peptidase proteolytic subunit |
| chr17_+_7905912 | 2.05 |
ENST00000254854.4
|
GUCY2D
|
guanylate cyclase 2D, membrane (retina-specific) |
| chr20_-_56284816 | 2.03 |
ENST00000395819.3
ENST00000341744.3 |
PMEPA1
|
prostate transmembrane protein, androgen induced 1 |
| chr7_-_44229022 | 2.00 |
ENST00000403799.3
|
GCK
|
glucokinase (hexokinase 4) |
| chr8_+_22423219 | 1.99 |
ENST00000523965.1
ENST00000521554.1 |
SORBS3
|
sorbin and SH3 domain containing 3 |
| chr15_+_67458357 | 1.97 |
ENST00000537194.2
|
SMAD3
|
SMAD family member 3 |
| chr21_-_45196326 | 1.96 |
ENST00000291568.5
|
CSTB
|
cystatin B (stefin B) |
| chr5_-_132112907 | 1.95 |
ENST00000458488.2
|
SEPT8
|
septin 8 |
| chr1_+_26606608 | 1.94 |
ENST00000319041.6
|
SH3BGRL3
|
SH3 domain binding glutamic acid-rich protein like 3 |
| chr17_+_36584662 | 1.93 |
ENST00000431231.2
ENST00000437668.3 |
ARHGAP23
|
Rho GTPase activating protein 23 |
| chr19_-_43708378 | 1.92 |
ENST00000599746.1
|
PSG4
|
pregnancy specific beta-1-glycoprotein 4 |
| chr17_-_39968406 | 1.91 |
ENST00000393928.1
|
LEPREL4
|
leprecan-like 4 |
| chr5_-_132112921 | 1.90 |
ENST00000378721.4
ENST00000378701.1 |
SEPT8
|
septin 8 |
| chr2_+_113816685 | 1.88 |
ENST00000393200.2
|
IL36RN
|
interleukin 36 receptor antagonist |
| chr10_+_54074033 | 1.88 |
ENST00000373970.3
|
DKK1
|
dickkopf WNT signaling pathway inhibitor 1 |
| chr9_+_116037922 | 1.86 |
ENST00000374198.4
|
PRPF4
|
pre-mRNA processing factor 4 |
| chr15_+_41523417 | 1.85 |
ENST00000560397.1
|
CHP1
|
calcineurin-like EF-hand protein 1 |
| chr17_-_39211463 | 1.85 |
ENST00000542910.1
ENST00000398477.1 |
KRTAP2-2
|
keratin associated protein 2-2 |
| chr8_+_26371763 | 1.85 |
ENST00000521913.1
|
DPYSL2
|
dihydropyrimidinase-like 2 |
| chr19_+_6361841 | 1.83 |
ENST00000596605.1
|
CLPP
|
caseinolytic mitochondrial matrix peptidase proteolytic subunit |
| chr13_-_103046837 | 1.81 |
ENST00000607251.1
|
FGF14-IT1
|
FGF14 intronic transcript 1 (non-protein coding) |
| chr17_-_27278445 | 1.79 |
ENST00000268756.3
ENST00000584685.1 |
PHF12
|
PHD finger protein 12 |
| chr12_-_48152611 | 1.78 |
ENST00000389212.3
|
RAPGEF3
|
Rap guanine nucleotide exchange factor (GEF) 3 |
| chr19_+_6361440 | 1.78 |
ENST00000245816.4
|
CLPP
|
caseinolytic mitochondrial matrix peptidase proteolytic subunit |
| chr2_+_228337079 | 1.77 |
ENST00000409315.1
ENST00000373671.3 ENST00000409171.1 |
AGFG1
|
ArfGAP with FG repeats 1 |
| chr9_+_103235365 | 1.77 |
ENST00000374879.4
|
TMEFF1
|
transmembrane protein with EGF-like and two follistatin-like domains 1 |
| chr20_-_44539538 | 1.76 |
ENST00000372420.1
|
PLTP
|
phospholipid transfer protein |
| chr19_-_51143075 | 1.75 |
ENST00000600079.1
ENST00000593901.1 |
SYT3
|
synaptotagmin III |
| chr20_+_44637526 | 1.72 |
ENST00000372330.3
|
MMP9
|
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) |
| chr19_-_50143452 | 1.70 |
ENST00000246792.3
|
RRAS
|
related RAS viral (r-ras) oncogene homolog |
| chr19_-_4124079 | 1.70 |
ENST00000394867.4
ENST00000262948.5 |
MAP2K2
|
mitogen-activated protein kinase kinase 2 |
| chr11_+_44117741 | 1.70 |
ENST00000395673.3
ENST00000343631.3 |
EXT2
|
exostosin glycosyltransferase 2 |
| chr11_+_65407331 | 1.70 |
ENST00000527525.1
|
SIPA1
|
signal-induced proliferation-associated 1 |
| chr20_-_36793663 | 1.67 |
ENST00000536701.1
ENST00000536724.1 |
TGM2
|
transglutaminase 2 |
| chr21_-_46962379 | 1.65 |
ENST00000311124.4
ENST00000380010.4 |
SLC19A1
|
solute carrier family 19 (folate transporter), member 1 |
| chr12_-_109125285 | 1.64 |
ENST00000552871.1
ENST00000261401.3 |
CORO1C
|
coronin, actin binding protein, 1C |
| chr6_+_43738444 | 1.64 |
ENST00000324450.6
ENST00000417285.2 ENST00000413642.3 ENST00000372055.4 ENST00000482630.2 ENST00000425836.2 ENST00000372064.4 ENST00000372077.4 ENST00000519767.1 |
VEGFA
|
vascular endothelial growth factor A |
| chr20_-_36793774 | 1.64 |
ENST00000361475.2
|
TGM2
|
transglutaminase 2 |
| chr12_-_48152428 | 1.61 |
ENST00000449771.2
ENST00000395358.3 |
RAPGEF3
|
Rap guanine nucleotide exchange factor (GEF) 3 |
| chr15_+_67430339 | 1.61 |
ENST00000439724.3
|
SMAD3
|
SMAD family member 3 |
| chr17_+_42923686 | 1.61 |
ENST00000591513.1
|
HIGD1B
|
HIG1 hypoxia inducible domain family, member 1B |
| chr21_-_47648665 | 1.60 |
ENST00000450351.1
ENST00000522411.1 ENST00000356396.4 ENST00000397728.3 ENST00000457828.2 |
LSS
|
lanosterol synthase (2,3-oxidosqualene-lanosterol cyclase) |
| chrX_+_38420783 | 1.60 |
ENST00000422612.2
ENST00000286824.6 ENST00000545599.1 |
TSPAN7
|
tetraspanin 7 |
| chr20_+_62694834 | 1.60 |
ENST00000415602.1
|
TCEA2
|
transcription elongation factor A (SII), 2 |
| chr3_-_28390120 | 1.59 |
ENST00000334100.6
|
AZI2
|
5-azacytidine induced 2 |
| chr1_-_245134273 | 1.58 |
ENST00000607453.1
|
RP11-156E8.1
|
Uncharacterized protein |
| chr17_-_39222131 | 1.58 |
ENST00000394015.2
|
KRTAP2-4
|
keratin associated protein 2-4 |
| chr6_-_42185583 | 1.57 |
ENST00000053468.3
|
MRPS10
|
mitochondrial ribosomal protein S10 |
| chr5_-_131563501 | 1.56 |
ENST00000401867.1
ENST00000379086.1 ENST00000418055.1 ENST00000453286.1 ENST00000166534.4 |
P4HA2
|
prolyl 4-hydroxylase, alpha polypeptide II |
| chr7_+_100136811 | 1.56 |
ENST00000300176.4
ENST00000262935.4 |
AGFG2
|
ArfGAP with FG repeats 2 |
| chr17_-_76921459 | 1.54 |
ENST00000262768.7
|
TIMP2
|
TIMP metallopeptidase inhibitor 2 |
| chr6_-_105850937 | 1.54 |
ENST00000369110.3
|
PREP
|
prolyl endopeptidase |
| chr5_-_137667459 | 1.53 |
ENST00000415130.2
ENST00000356505.3 ENST00000357274.3 ENST00000348983.3 ENST00000323760.6 |
CDC25C
|
cell division cycle 25C |
| chr1_+_10092890 | 1.51 |
ENST00000253251.8
ENST00000377157.3 |
UBE4B
|
ubiquitination factor E4B |
| chr11_+_65405556 | 1.51 |
ENST00000534313.1
ENST00000533361.1 ENST00000526137.1 |
SIPA1
|
signal-induced proliferation-associated 1 |
| chr3_+_185300391 | 1.50 |
ENST00000545472.1
|
SENP2
|
SUMO1/sentrin/SMT3 specific peptidase 2 |
| chr17_-_49198095 | 1.50 |
ENST00000505279.1
|
SPAG9
|
sperm associated antigen 9 |
| chr22_-_30234218 | 1.50 |
ENST00000307790.3
ENST00000542393.1 ENST00000397771.2 |
ASCC2
|
activating signal cointegrator 1 complex subunit 2 |
| chr2_+_173600514 | 1.50 |
ENST00000264111.6
|
RAPGEF4
|
Rap guanine nucleotide exchange factor (GEF) 4 |
| chr19_-_4723761 | 1.47 |
ENST00000597849.1
ENST00000598800.1 ENST00000602161.1 ENST00000597726.1 ENST00000601130.1 ENST00000262960.9 |
DPP9
|
dipeptidyl-peptidase 9 |
| chr7_-_3083573 | 1.45 |
ENST00000396946.4
|
CARD11
|
caspase recruitment domain family, member 11 |
| chr19_-_52227221 | 1.45 |
ENST00000222115.1
ENST00000540069.2 |
HAS1
|
hyaluronan synthase 1 |
| chr14_+_76776957 | 1.45 |
ENST00000512784.1
|
ESRRB
|
estrogen-related receptor beta |
| chr20_+_18568537 | 1.45 |
ENST00000377452.3
|
DTD1
|
D-tyrosyl-tRNA deacylase 1 |
| chr17_+_7210921 | 1.44 |
ENST00000573542.1
|
EIF5A
|
eukaryotic translation initiation factor 5A |
| chr13_+_114321463 | 1.44 |
ENST00000335678.6
|
GRK1
|
G protein-coupled receptor kinase 1 |
| chr11_+_63753883 | 1.44 |
ENST00000538426.1
ENST00000543004.1 |
OTUB1
|
OTU domain, ubiquitin aldehyde binding 1 |
| chr19_+_6361754 | 1.43 |
ENST00000597326.1
|
CLPP
|
caseinolytic mitochondrial matrix peptidase proteolytic subunit |
| chr11_+_12308447 | 1.43 |
ENST00000256186.2
|
MICALCL
|
MICAL C-terminal like |
| chr1_+_160051319 | 1.43 |
ENST00000368088.3
|
KCNJ9
|
potassium inwardly-rectifying channel, subfamily J, member 9 |
| chr20_+_30467600 | 1.43 |
ENST00000375934.4
ENST00000375922.4 |
TTLL9
|
tubulin tyrosine ligase-like family, member 9 |
| chr17_-_39968855 | 1.41 |
ENST00000355468.3
ENST00000590496.1 |
LEPREL4
|
leprecan-like 4 |
| chr8_-_11058847 | 1.40 |
ENST00000297303.4
ENST00000416569.2 |
XKR6
|
XK, Kell blood group complex subunit-related family, member 6 |
| chr9_+_124413873 | 1.38 |
ENST00000408936.3
|
DAB2IP
|
DAB2 interacting protein |
| chr22_+_37447771 | 1.38 |
ENST00000402077.3
ENST00000403888.3 ENST00000456470.1 |
KCTD17
|
potassium channel tetramerization domain containing 17 |
| chr3_+_38206975 | 1.37 |
ENST00000446845.1
ENST00000311806.3 |
OXSR1
|
oxidative stress responsive 1 |
| chr17_-_79139817 | 1.37 |
ENST00000326724.4
|
AATK
|
apoptosis-associated tyrosine kinase |
| chr19_-_47354082 | 1.36 |
ENST00000593442.1
ENST00000263270.6 |
AP2S1
|
adaptor-related protein complex 2, sigma 1 subunit |
| chr20_-_50808236 | 1.36 |
ENST00000361387.2
|
ZFP64
|
ZFP64 zinc finger protein |
| chrX_+_38420623 | 1.36 |
ENST00000378482.2
|
TSPAN7
|
tetraspanin 7 |
| chr1_-_155880672 | 1.36 |
ENST00000609492.1
ENST00000368322.3 |
RIT1
|
Ras-like without CAAX 1 |
| chr6_+_42018614 | 1.33 |
ENST00000465926.1
ENST00000482432.1 |
TAF8
|
TAF8 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 43kDa |
| chr17_-_39216344 | 1.33 |
ENST00000391418.2
|
KRTAP2-3
|
keratin associated protein 2-3 |
| chr9_-_132515302 | 1.33 |
ENST00000340607.4
|
PTGES
|
prostaglandin E synthase |
| chr14_+_37126765 | 1.33 |
ENST00000402703.2
|
PAX9
|
paired box 9 |
| chr22_+_38093005 | 1.32 |
ENST00000406386.3
|
TRIOBP
|
TRIO and F-actin binding protein |
| chr19_-_47354023 | 1.32 |
ENST00000601649.1
ENST00000599990.1 ENST00000352203.4 |
AP2S1
|
adaptor-related protein complex 2, sigma 1 subunit |
| chr8_+_27632083 | 1.31 |
ENST00000519637.1
|
ESCO2
|
establishment of sister chromatid cohesion N-acetyltransferase 2 |
| chr17_+_7211656 | 1.30 |
ENST00000416016.2
|
EIF5A
|
eukaryotic translation initiation factor 5A |
| chr16_+_69458537 | 1.30 |
ENST00000515314.1
ENST00000561792.1 ENST00000568237.1 |
CYB5B
|
cytochrome b5 type B (outer mitochondrial membrane) |
| chr8_+_97274119 | 1.29 |
ENST00000455950.2
|
PTDSS1
|
phosphatidylserine synthase 1 |
| chr19_-_36001286 | 1.29 |
ENST00000602679.1
ENST00000492341.2 ENST00000472252.2 ENST00000602781.1 ENST00000402589.2 ENST00000458071.1 ENST00000436012.1 ENST00000443640.1 ENST00000450261.1 ENST00000467637.1 ENST00000480502.1 ENST00000474928.1 ENST00000414866.2 ENST00000392206.2 ENST00000488892.1 |
DMKN
|
dermokine |
| chr12_-_122241812 | 1.28 |
ENST00000538335.1
|
AC084018.1
|
AC084018.1 |
| chr3_-_122102065 | 1.28 |
ENST00000479899.1
ENST00000291458.5 ENST00000497726.1 |
CCDC58
|
coiled-coil domain containing 58 |
| chr3_-_28390298 | 1.26 |
ENST00000457172.1
|
AZI2
|
5-azacytidine induced 2 |
| chr2_+_173600565 | 1.26 |
ENST00000397081.3
|
RAPGEF4
|
Rap guanine nucleotide exchange factor (GEF) 4 |
| chr22_-_32058166 | 1.26 |
ENST00000435900.1
ENST00000336566.4 |
PISD
|
phosphatidylserine decarboxylase |
| chr7_-_767249 | 1.25 |
ENST00000403562.1
|
PRKAR1B
|
protein kinase, cAMP-dependent, regulatory, type I, beta |
| chr7_+_30068260 | 1.24 |
ENST00000440706.2
|
PLEKHA8
|
pleckstrin homology domain containing, family A (phosphoinositide binding specific) member 8 |
| chr22_+_24309089 | 1.24 |
ENST00000215770.5
|
DDTL
|
D-dopachrome tautomerase-like |
| chr19_-_47353547 | 1.24 |
ENST00000601498.1
|
AP2S1
|
adaptor-related protein complex 2, sigma 1 subunit |
| chrX_+_48911090 | 1.24 |
ENST00000597275.1
|
CCDC120
|
coiled-coil domain containing 120 |
| chr9_+_34653861 | 1.23 |
ENST00000556792.1
ENST00000318041.9 ENST00000378817.4 |
IL11RA
|
interleukin 11 receptor, alpha |
| chr17_+_47074758 | 1.22 |
ENST00000290341.3
|
IGF2BP1
|
insulin-like growth factor 2 mRNA binding protein 1 |
| chr3_-_16555150 | 1.21 |
ENST00000334133.4
|
RFTN1
|
raftlin, lipid raft linker 1 |
| chr16_+_28889801 | 1.21 |
ENST00000395503.4
|
ATP2A1
|
ATPase, Ca++ transporting, cardiac muscle, fast twitch 1 |
| chr19_-_15560730 | 1.21 |
ENST00000389282.4
ENST00000263381.7 |
WIZ
|
widely interspaced zinc finger motifs |
| chr6_-_2971494 | 1.20 |
ENST00000380539.1
|
SERPINB6
|
serpin peptidase inhibitor, clade B (ovalbumin), member 6 |
| chr9_+_125027127 | 1.20 |
ENST00000441707.1
ENST00000373723.5 ENST00000373729.1 |
MRRF
|
mitochondrial ribosome recycling factor |
| chr2_+_202316392 | 1.19 |
ENST00000194530.3
ENST00000392249.2 |
STRADB
|
STE20-related kinase adaptor beta |
| chr17_-_1394940 | 1.19 |
ENST00000570984.2
ENST00000361007.2 |
MYO1C
|
myosin IC |
| chr1_+_23037323 | 1.19 |
ENST00000544305.1
ENST00000374630.3 ENST00000400191.3 ENST00000374632.3 |
EPHB2
|
EPH receptor B2 |
| chr5_-_137667526 | 1.18 |
ENST00000503022.1
|
CDC25C
|
cell division cycle 25C |
| chr11_-_2162162 | 1.18 |
ENST00000381389.1
|
IGF2
|
insulin-like growth factor 2 (somatomedin A) |
| chr17_+_7210852 | 1.18 |
ENST00000576930.1
|
EIF5A
|
eukaryotic translation initiation factor 5A |
| chr9_+_34179003 | 1.17 |
ENST00000545103.1
ENST00000543944.1 ENST00000536252.1 ENST00000540348.1 ENST00000297661.4 ENST00000379186.4 |
UBAP1
|
ubiquitin associated protein 1 |
| chr3_+_160117418 | 1.17 |
ENST00000465903.1
ENST00000485645.1 ENST00000360111.2 ENST00000472991.1 ENST00000467468.1 ENST00000469762.1 ENST00000489573.1 ENST00000462787.1 ENST00000490207.1 ENST00000485867.1 |
SMC4
|
structural maintenance of chromosomes 4 |
| chr22_-_37584321 | 1.17 |
ENST00000397110.2
ENST00000337843.2 |
C1QTNF6
|
C1q and tumor necrosis factor related protein 6 |
| chr19_+_41882466 | 1.17 |
ENST00000436170.2
|
TMEM91
|
transmembrane protein 91 |
| chr19_+_19496728 | 1.16 |
ENST00000537887.1
ENST00000417582.2 |
GATAD2A
|
GATA zinc finger domain containing 2A |
| chr22_+_46692638 | 1.16 |
ENST00000454366.1
|
GTSE1
|
G-2 and S-phase expressed 1 |
| chr2_-_220408430 | 1.15 |
ENST00000243776.6
|
CHPF
|
chondroitin polymerizing factor |
| chr19_-_14228541 | 1.15 |
ENST00000590853.1
ENST00000308677.4 |
PRKACA
|
protein kinase, cAMP-dependent, catalytic, alpha |
| chr7_-_94285402 | 1.15 |
ENST00000428696.2
ENST00000445866.2 |
SGCE
|
sarcoglycan, epsilon |
| chr22_-_38699003 | 1.14 |
ENST00000451964.1
|
CSNK1E
|
casein kinase 1, epsilon |
| chr2_-_228028829 | 1.14 |
ENST00000396625.3
ENST00000329662.7 |
COL4A4
|
collagen, type IV, alpha 4 |
| chr2_+_233243233 | 1.14 |
ENST00000392027.2
|
ALPP
|
alkaline phosphatase, placental |
| chr19_+_39390320 | 1.14 |
ENST00000576510.1
|
NFKBIB
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, beta |
| chr5_+_133861339 | 1.13 |
ENST00000282605.4
ENST00000361895.2 ENST00000402835.1 |
PHF15
|
jade family PHD finger 2 |
| chr22_-_20368028 | 1.13 |
ENST00000404912.1
|
GGTLC3
|
gamma-glutamyltransferase light chain 3 |
| chr14_-_77787198 | 1.13 |
ENST00000261534.4
|
POMT2
|
protein-O-mannosyltransferase 2 |
Network of associatons between targets according to the STRING database.
First level regulatory network of RXRG
Gene Ontology Analysis
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 3.3 | 10.0 | GO:0000412 | histone peptidyl-prolyl isomerization(GO:0000412) |
| 1.9 | 5.7 | GO:0045659 | regulation of neutrophil differentiation(GO:0045658) negative regulation of neutrophil differentiation(GO:0045659) |
| 1.8 | 5.3 | GO:1903609 | negative regulation of peptidyl-tyrosine autophosphorylation(GO:1900085) negative regulation of inward rectifier potassium channel activity(GO:1903609) |
| 1.7 | 5.0 | GO:0015728 | mevalonate transport(GO:0015728) behavioral response to nutrient(GO:0051780) |
| 1.6 | 4.9 | GO:1903570 | regulation of protein kinase D signaling(GO:1903570) positive regulation of protein kinase D signaling(GO:1903572) |
| 1.2 | 9.4 | GO:0045905 | translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
| 1.1 | 3.3 | GO:0018153 | isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine(GO:0018153) isopeptide cross-linking(GO:0018262) |
| 1.0 | 4.2 | GO:1900104 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
| 0.9 | 2.8 | GO:0018894 | dibenzo-p-dioxin metabolic process(GO:0018894) cellular alkene metabolic process(GO:0043449) |
| 0.9 | 2.8 | GO:0014740 | negative regulation of muscle hyperplasia(GO:0014740) |
| 0.9 | 4.6 | GO:0044565 | dendritic cell proliferation(GO:0044565) |
| 0.8 | 3.4 | GO:0030822 | positive regulation of cyclic nucleotide catabolic process(GO:0030807) positive regulation of cAMP catabolic process(GO:0030822) positive regulation of purine nucleotide catabolic process(GO:0033123) |
| 0.8 | 6.7 | GO:0031642 | negative regulation of myelination(GO:0031642) |
| 0.8 | 2.3 | GO:0014724 | regulation of twitch skeletal muscle contraction(GO:0014724) fast-twitch skeletal muscle fiber contraction(GO:0031443) relaxation of skeletal muscle(GO:0090076) |
| 0.7 | 3.0 | GO:1900533 | medium-chain fatty-acyl-CoA catabolic process(GO:0036114) long-chain fatty-acyl-CoA catabolic process(GO:0036116) palmitic acid metabolic process(GO:1900533) palmitic acid biosynthetic process(GO:1900535) |
| 0.7 | 1.5 | GO:0046379 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
| 0.7 | 3.6 | GO:0061767 | negative regulation of lung blood pressure(GO:0061767) |
| 0.7 | 2.1 | GO:1901860 | positive regulation of mitochondrial DNA metabolic process(GO:1901860) |
| 0.7 | 2.1 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) meiotic recombination checkpoint(GO:0051598) |
| 0.7 | 2.7 | GO:0021812 | neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
| 0.6 | 3.2 | GO:0042631 | cellular response to water deprivation(GO:0042631) |
| 0.6 | 1.9 | GO:0042663 | regulation of endodermal cell fate specification(GO:0042663) |
| 0.6 | 2.4 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
| 0.6 | 3.5 | GO:0071105 | response to interleukin-11(GO:0071105) |
| 0.6 | 1.7 | GO:0098838 | reduced folate transmembrane transport(GO:0098838) |
| 0.5 | 3.2 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
| 0.5 | 5.3 | GO:0098734 | macromolecule depalmitoylation(GO:0098734) |
| 0.5 | 4.5 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
| 0.5 | 1.5 | GO:0000117 | regulation of transcription involved in G2/M transition of mitotic cell cycle(GO:0000117) |
| 0.5 | 2.3 | GO:0061034 | olfactory bulb mitral cell layer development(GO:0061034) |
| 0.5 | 1.4 | GO:2000681 | negative regulation of rubidium ion transport(GO:2000681) negative regulation of rubidium ion transmembrane transporter activity(GO:2000687) |
| 0.5 | 1.4 | GO:2000777 | positive regulation of oocyte maturation(GO:1900195) positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia(GO:2000777) |
| 0.4 | 1.8 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
| 0.4 | 2.5 | GO:0061502 | negative regulation of vesicle fusion(GO:0031339) early endosome to recycling endosome transport(GO:0061502) |
| 0.4 | 2.3 | GO:0001661 | conditioned taste aversion(GO:0001661) |
| 0.4 | 3.5 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
| 0.4 | 6.6 | GO:0071459 | protein localization to chromosome, centromeric region(GO:0071459) |
| 0.4 | 1.1 | GO:0042938 | dipeptide transport(GO:0042938) |
| 0.3 | 1.4 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
| 0.3 | 4.4 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
| 0.3 | 2.7 | GO:0046836 | glycolipid transport(GO:0046836) |
| 0.3 | 1.7 | GO:0009732 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
| 0.3 | 2.6 | GO:0035897 | proteolysis in other organism(GO:0035897) |
| 0.3 | 3.6 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
| 0.3 | 1.9 | GO:1902766 | skeletal muscle satellite cell migration(GO:1902766) |
| 0.3 | 3.4 | GO:0098795 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
| 0.3 | 1.5 | GO:0032487 | regulation of Rap protein signal transduction(GO:0032487) |
| 0.3 | 0.9 | GO:1901899 | positive regulation of relaxation of cardiac muscle(GO:1901899) regulation of calcium ion import into sarcoplasmic reticulum(GO:1902080) negative regulation of calcium ion import into sarcoplasmic reticulum(GO:1902081) |
| 0.3 | 1.5 | GO:0001834 | trophectodermal cell proliferation(GO:0001834) regulation of trophectodermal cell proliferation(GO:1904073) positive regulation of trophectodermal cell proliferation(GO:1904075) |
| 0.3 | 2.4 | GO:0070885 | positive regulation of sodium:proton antiporter activity(GO:0032417) negative regulation of calcineurin-NFAT signaling cascade(GO:0070885) |
| 0.3 | 0.9 | GO:0098968 | neurotransmitter receptor transport postsynaptic membrane to endosome(GO:0098968) |
| 0.3 | 0.9 | GO:1904395 | positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) |
| 0.3 | 2.8 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
| 0.3 | 1.4 | GO:0043553 | vascular endothelial growth factor receptor-2 signaling pathway(GO:0036324) negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
| 0.3 | 0.8 | GO:0098976 | excitatory chemical synaptic transmission(GO:0098976) regulation of AMPA glutamate receptor clustering(GO:1904717) positive regulation of AMPA glutamate receptor clustering(GO:1904719) |
| 0.3 | 0.8 | GO:0050894 | determination of affect(GO:0050894) |
| 0.3 | 2.1 | GO:0021860 | pyramidal neuron differentiation(GO:0021859) pyramidal neuron development(GO:0021860) |
| 0.3 | 1.9 | GO:1902714 | negative regulation of interferon-gamma secretion(GO:1902714) |
| 0.3 | 3.2 | GO:0010968 | regulation of microtubule nucleation(GO:0010968) |
| 0.3 | 1.3 | GO:0030047 | actin modification(GO:0030047) |
| 0.3 | 5.0 | GO:0030949 | positive regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030949) |
| 0.3 | 11.8 | GO:0014059 | dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
| 0.3 | 1.6 | GO:0000432 | regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) |
| 0.3 | 0.3 | GO:0002188 | translation reinitiation(GO:0002188) |
| 0.3 | 1.0 | GO:2000230 | response to metformin(GO:1901558) negative regulation of pancreatic stellate cell proliferation(GO:2000230) |
| 0.3 | 2.0 | GO:0060017 | parathyroid gland development(GO:0060017) |
| 0.2 | 1.7 | GO:0051549 | positive regulation of keratinocyte migration(GO:0051549) |
| 0.2 | 0.7 | GO:0048213 | Golgi vesicle prefusion complex stabilization(GO:0048213) |
| 0.2 | 0.7 | GO:0007518 | myoblast fate determination(GO:0007518) |
| 0.2 | 1.0 | GO:0075509 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
| 0.2 | 1.9 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
| 0.2 | 3.1 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
| 0.2 | 0.7 | GO:1900220 | semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
| 0.2 | 1.1 | GO:1904098 | regulation of protein O-linked glycosylation(GO:1904098) positive regulation of protein O-linked glycosylation(GO:1904100) |
| 0.2 | 1.3 | GO:0045903 | positive regulation of translational fidelity(GO:0045903) |
| 0.2 | 0.7 | GO:0050902 | leukocyte adhesive activation(GO:0050902) |
| 0.2 | 0.7 | GO:0000494 | box C/D snoRNA 3'-end processing(GO:0000494) box C/D snoRNA metabolic process(GO:0033967) box C/D snoRNA processing(GO:0034963) histone glutamine methylation(GO:1990258) |
| 0.2 | 1.5 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
| 0.2 | 1.3 | GO:1903575 | cornified envelope assembly(GO:1903575) |
| 0.2 | 1.5 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
| 0.2 | 0.2 | GO:1901207 | regulation of heart looping(GO:1901207) |
| 0.2 | 1.2 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
| 0.2 | 2.4 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
| 0.2 | 1.0 | GO:0003430 | growth plate cartilage chondrocyte growth(GO:0003430) Harderian gland development(GO:0070384) |
| 0.2 | 0.8 | GO:0071484 | cellular response to light intensity(GO:0071484) |
| 0.2 | 4.1 | GO:0032802 | low-density lipoprotein particle receptor catabolic process(GO:0032802) |
| 0.2 | 2.0 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
| 0.2 | 0.5 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
| 0.2 | 1.1 | GO:0031022 | nuclear migration along microfilament(GO:0031022) |
| 0.2 | 1.1 | GO:0051012 | microtubule sliding(GO:0051012) |
| 0.2 | 2.1 | GO:0032790 | ribosome disassembly(GO:0032790) |
| 0.2 | 0.5 | GO:0071442 | positive regulation of histone H3-K14 acetylation(GO:0071442) |
| 0.2 | 3.9 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
| 0.2 | 0.9 | GO:0044571 | [2Fe-2S] cluster assembly(GO:0044571) |
| 0.2 | 1.2 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
| 0.2 | 0.5 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
| 0.2 | 0.5 | GO:1902463 | protein localization to cell leading edge(GO:1902463) |
| 0.2 | 0.5 | GO:0071879 | UDP-glucose catabolic process(GO:0006258) positive regulation of adrenergic receptor signaling pathway(GO:0071879) |
| 0.2 | 1.7 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
| 0.2 | 2.2 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
| 0.2 | 0.7 | GO:0014038 | regulation of Schwann cell differentiation(GO:0014038) positive regulation of Schwann cell differentiation(GO:0014040) |
| 0.2 | 0.8 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
| 0.2 | 1.2 | GO:1904526 | regulation of microtubule binding(GO:1904526) |
| 0.2 | 1.6 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
| 0.2 | 0.6 | GO:1904046 | negative regulation of vascular endothelial growth factor production(GO:1904046) |
| 0.2 | 0.6 | GO:1903862 | positive regulation of oxidative phosphorylation(GO:1903862) |
| 0.2 | 0.8 | GO:1902162 | mRNA localization resulting in posttranscriptional regulation of gene expression(GO:0010609) regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902162) positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902164) |
| 0.2 | 0.9 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
| 0.2 | 0.9 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
| 0.1 | 0.9 | GO:0032468 | Golgi calcium ion homeostasis(GO:0032468) |
| 0.1 | 2.8 | GO:0070508 | sterol import(GO:0035376) cholesterol import(GO:0070508) |
| 0.1 | 1.2 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
| 0.1 | 0.3 | GO:1903224 | regulation of endodermal cell differentiation(GO:1903224) |
| 0.1 | 0.6 | GO:0097460 | ferrous iron import into cell(GO:0097460) ferrous iron import across plasma membrane(GO:0098707) |
| 0.1 | 1.5 | GO:0046498 | S-adenosylhomocysteine metabolic process(GO:0046498) |
| 0.1 | 1.5 | GO:0016926 | protein desumoylation(GO:0016926) |
| 0.1 | 1.8 | GO:0001675 | acrosome assembly(GO:0001675) |
| 0.1 | 0.8 | GO:0061668 | mitochondrial ribosome assembly(GO:0061668) |
| 0.1 | 1.1 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
| 0.1 | 0.9 | GO:1901315 | negative regulation of histone ubiquitination(GO:0033183) regulation of histone H2A K63-linked ubiquitination(GO:1901314) negative regulation of histone H2A K63-linked ubiquitination(GO:1901315) |
| 0.1 | 1.5 | GO:0070970 | interleukin-2 secretion(GO:0070970) |
| 0.1 | 1.2 | GO:1904783 | positive regulation of NMDA glutamate receptor activity(GO:1904783) |
| 0.1 | 1.2 | GO:2000467 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) positive regulation of glycogen (starch) synthase activity(GO:2000467) |
| 0.1 | 0.9 | GO:0086048 | membrane depolarization during bundle of His cell action potential(GO:0086048) |
| 0.1 | 2.1 | GO:0006705 | mineralocorticoid biosynthetic process(GO:0006705) mineralocorticoid metabolic process(GO:0008212) |
| 0.1 | 1.0 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
| 0.1 | 1.1 | GO:0034465 | response to carbon monoxide(GO:0034465) |
| 0.1 | 2.4 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
| 0.1 | 1.0 | GO:0050428 | purine ribonucleoside bisphosphate biosynthetic process(GO:0034036) 3'-phosphoadenosine 5'-phosphosulfate biosynthetic process(GO:0050428) |
| 0.1 | 1.0 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
| 0.1 | 7.9 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) |
| 0.1 | 2.2 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
| 0.1 | 0.3 | GO:0032581 | ER-dependent peroxisome organization(GO:0032581) |
| 0.1 | 0.7 | GO:0006021 | inositol biosynthetic process(GO:0006021) |
| 0.1 | 1.0 | GO:0098887 | neurotransmitter receptor transport, endosome to postsynaptic membrane(GO:0098887) |
| 0.1 | 3.7 | GO:0007020 | microtubule nucleation(GO:0007020) |
| 0.1 | 0.7 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
| 0.1 | 0.4 | GO:0035617 | stress granule disassembly(GO:0035617) |
| 0.1 | 1.4 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
| 0.1 | 0.5 | GO:0000023 | maltose metabolic process(GO:0000023) |
| 0.1 | 1.5 | GO:0017085 | response to insecticide(GO:0017085) |
| 0.1 | 0.5 | GO:0035105 | sterol regulatory element binding protein import into nucleus(GO:0035105) |
| 0.1 | 0.5 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
| 0.1 | 0.4 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
| 0.1 | 0.6 | GO:0015798 | myo-inositol transport(GO:0015798) |
| 0.1 | 0.4 | GO:0009227 | nucleotide-sugar catabolic process(GO:0009227) |
| 0.1 | 0.9 | GO:0034626 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
| 0.1 | 0.4 | GO:0000957 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
| 0.1 | 1.1 | GO:0090261 | positive regulation of inclusion body assembly(GO:0090261) |
| 0.1 | 3.0 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 0.1 | 0.8 | GO:0035873 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) |
| 0.1 | 1.0 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
| 0.1 | 0.8 | GO:2000576 | regulation of microtubule motor activity(GO:2000574) positive regulation of microtubule motor activity(GO:2000576) regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000580) positive regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000582) |
| 0.1 | 0.9 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
| 0.1 | 0.9 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
| 0.1 | 0.9 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
| 0.1 | 0.8 | GO:0007256 | activation of JNKK activity(GO:0007256) |
| 0.1 | 0.4 | GO:0009635 | response to herbicide(GO:0009635) |
| 0.1 | 1.6 | GO:0090344 | negative regulation of cell aging(GO:0090344) |
| 0.1 | 0.6 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
| 0.1 | 0.4 | GO:1904016 | response to Thyroglobulin triiodothyronine(GO:1904016) |
| 0.1 | 1.1 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
| 0.1 | 0.7 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
| 0.1 | 0.8 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
| 0.1 | 1.1 | GO:0032025 | response to cobalt ion(GO:0032025) |
| 0.1 | 0.8 | GO:0033227 | dsRNA transport(GO:0033227) |
| 0.1 | 0.8 | GO:0098868 | endochondral bone growth(GO:0003416) bone growth(GO:0098868) |
| 0.1 | 2.7 | GO:1902751 | positive regulation of cell cycle G2/M phase transition(GO:1902751) |
| 0.1 | 3.0 | GO:0060325 | face morphogenesis(GO:0060325) |
| 0.1 | 0.3 | GO:2001295 | malonyl-CoA biosynthetic process(GO:2001295) |
| 0.1 | 0.6 | GO:0035965 | cardiolipin acyl-chain remodeling(GO:0035965) |
| 0.1 | 3.1 | GO:0007176 | regulation of epidermal growth factor-activated receptor activity(GO:0007176) |
| 0.1 | 0.9 | GO:1904263 | positive regulation of TORC1 signaling(GO:1904263) |
| 0.1 | 0.5 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
| 0.1 | 1.4 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
| 0.1 | 1.0 | GO:0015074 | DNA integration(GO:0015074) |
| 0.1 | 0.5 | GO:0015811 | L-cystine transport(GO:0015811) |
| 0.1 | 1.3 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
| 0.1 | 0.9 | GO:0006657 | CDP-choline pathway(GO:0006657) |
| 0.1 | 0.6 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
| 0.1 | 0.4 | GO:0032488 | Cdc42 protein signal transduction(GO:0032488) |
| 0.1 | 0.4 | GO:0035524 | proline transmembrane transport(GO:0035524) |
| 0.1 | 1.0 | GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) |
| 0.1 | 0.3 | GO:1903336 | endosome localization(GO:0032439) negative regulation of vacuolar transport(GO:1903336) |
| 0.1 | 0.7 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
| 0.1 | 0.9 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
| 0.1 | 1.1 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
| 0.1 | 0.9 | GO:0042438 | melanin metabolic process(GO:0006582) melanin biosynthetic process(GO:0042438) |
| 0.1 | 0.2 | GO:0036446 | myofibroblast differentiation(GO:0036446) epithelial to mesenchymal transition involved in cardiac fibroblast development(GO:0060940) regulation of myofibroblast differentiation(GO:1904760) |
| 0.1 | 1.1 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
| 0.1 | 1.5 | GO:0030728 | ovulation(GO:0030728) |
| 0.1 | 0.2 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
| 0.1 | 0.3 | GO:0061084 | regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) |
| 0.1 | 1.7 | GO:0010800 | positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
| 0.1 | 0.6 | GO:0099612 | protein localization to axon(GO:0099612) |
| 0.1 | 0.3 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
| 0.1 | 0.2 | GO:0002774 | Fc receptor mediated inhibitory signaling pathway(GO:0002774) |
| 0.1 | 1.2 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
| 0.1 | 0.8 | GO:0042118 | endothelial cell activation(GO:0042118) |
| 0.0 | 1.8 | GO:1903861 | positive regulation of dendrite extension(GO:1903861) |
| 0.0 | 0.4 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
| 0.0 | 3.2 | GO:0019933 | cAMP-mediated signaling(GO:0019933) |
| 0.0 | 1.1 | GO:0002230 | positive regulation of defense response to virus by host(GO:0002230) |
| 0.0 | 0.3 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
| 0.0 | 1.7 | GO:0032402 | melanosome transport(GO:0032402) |
| 0.0 | 0.6 | GO:0051438 | regulation of ubiquitin-protein transferase activity(GO:0051438) |
| 0.0 | 2.6 | GO:0043525 | positive regulation of neuron apoptotic process(GO:0043525) |
| 0.0 | 0.3 | GO:0002857 | positive regulation of natural killer cell mediated immune response to tumor cell(GO:0002857) positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002860) |
| 0.0 | 0.6 | GO:0070072 | proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
| 0.0 | 0.2 | GO:0072240 | thick ascending limb development(GO:0072023) DCT cell differentiation(GO:0072069) metanephric thick ascending limb development(GO:0072233) metanephric DCT cell differentiation(GO:0072240) |
| 0.0 | 0.9 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
| 0.0 | 1.4 | GO:0022400 | regulation of rhodopsin mediated signaling pathway(GO:0022400) |
| 0.0 | 0.8 | GO:0046426 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
| 0.0 | 0.6 | GO:0035493 | SNARE complex assembly(GO:0035493) |
| 0.0 | 0.3 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
| 0.0 | 0.6 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
| 0.0 | 0.5 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
| 0.0 | 0.3 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
| 0.0 | 0.6 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
| 0.0 | 0.5 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
| 0.0 | 0.2 | GO:0036101 | leukotriene catabolic process(GO:0036100) leukotriene B4 catabolic process(GO:0036101) leukotriene B4 metabolic process(GO:0036102) icosanoid catabolic process(GO:1901523) fatty acid derivative catabolic process(GO:1901569) |
| 0.0 | 0.5 | GO:0035418 | protein localization to synapse(GO:0035418) |
| 0.0 | 0.3 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
| 0.0 | 0.5 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
| 0.0 | 0.2 | GO:0000255 | allantoin metabolic process(GO:0000255) |
| 0.0 | 0.3 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
| 0.0 | 0.7 | GO:0048268 | clathrin coat assembly(GO:0048268) |
| 0.0 | 0.2 | GO:0015862 | uridine transport(GO:0015862) |
| 0.0 | 1.6 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
| 0.0 | 0.7 | GO:0070208 | protein heterotrimerization(GO:0070208) |
| 0.0 | 0.2 | GO:0035962 | response to interleukin-13(GO:0035962) |
| 0.0 | 0.4 | GO:0051964 | netrin-activated signaling pathway(GO:0038007) negative regulation of synapse assembly(GO:0051964) |
| 0.0 | 0.9 | GO:0016180 | snRNA processing(GO:0016180) |
| 0.0 | 0.1 | GO:0016256 | N-glycan processing to lysosome(GO:0016256) |
| 0.0 | 0.1 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
| 0.0 | 1.3 | GO:0010107 | potassium ion import(GO:0010107) |
| 0.0 | 0.2 | GO:0072526 | pyridine-containing compound catabolic process(GO:0072526) |
| 0.0 | 0.3 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
| 0.0 | 0.6 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
| 0.0 | 1.3 | GO:0045724 | positive regulation of cilium assembly(GO:0045724) |
| 0.0 | 1.5 | GO:0071470 | cellular response to osmotic stress(GO:0071470) |
| 0.0 | 0.1 | GO:0051142 | regulation of NK T cell proliferation(GO:0051140) positive regulation of NK T cell proliferation(GO:0051142) |
| 0.0 | 1.7 | GO:0045815 | positive regulation of gene expression, epigenetic(GO:0045815) |
| 0.0 | 1.5 | GO:2000249 | regulation of actin cytoskeleton reorganization(GO:2000249) |
| 0.0 | 0.2 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
| 0.0 | 0.6 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
| 0.0 | 0.5 | GO:0051290 | protein heterotetramerization(GO:0051290) |
| 0.0 | 1.4 | GO:1901099 | negative regulation of signal transduction in absence of ligand(GO:1901099) negative regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001240) |
| 0.0 | 1.2 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
| 0.0 | 1.6 | GO:0032784 | regulation of DNA-templated transcription, elongation(GO:0032784) |
| 0.0 | 0.7 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
| 0.0 | 5.3 | GO:0031424 | keratinization(GO:0031424) |
| 0.0 | 0.7 | GO:0002026 | regulation of the force of heart contraction(GO:0002026) |
| 0.0 | 0.1 | GO:0038195 | urokinase plasminogen activator signaling pathway(GO:0038195) |
| 0.0 | 0.1 | GO:2000110 | regulation of MyD88-dependent toll-like receptor signaling pathway(GO:0034124) negative regulation of macrophage apoptotic process(GO:2000110) |
| 0.0 | 2.0 | GO:0008344 | adult locomotory behavior(GO:0008344) |
| 0.0 | 0.6 | GO:1900273 | positive regulation of long-term synaptic potentiation(GO:1900273) |
| 0.0 | 1.8 | GO:0030834 | regulation of actin filament depolymerization(GO:0030834) |
| 0.0 | 1.1 | GO:0006308 | DNA catabolic process(GO:0006308) |
| 0.0 | 0.3 | GO:0014850 | response to muscle activity(GO:0014850) |
| 0.0 | 0.3 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
| 0.0 | 0.4 | GO:0007614 | short-term memory(GO:0007614) |
| 0.0 | 1.8 | GO:0006306 | DNA alkylation(GO:0006305) DNA methylation(GO:0006306) |
| 0.0 | 0.2 | GO:0007512 | adult heart development(GO:0007512) |
| 0.0 | 0.1 | GO:0016240 | autophagosome docking(GO:0016240) |
| 0.0 | 0.1 | GO:1901143 | insulin catabolic process(GO:1901143) |
| 0.0 | 1.2 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
| 0.0 | 0.4 | GO:0010919 | regulation of inositol phosphate biosynthetic process(GO:0010919) positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
| 0.0 | 0.1 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
| 0.0 | 0.8 | GO:0050690 | regulation of defense response to virus by virus(GO:0050690) |
| 0.0 | 0.6 | GO:0021846 | cell proliferation in forebrain(GO:0021846) |
| 0.0 | 0.2 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
| 0.0 | 1.0 | GO:0050982 | detection of mechanical stimulus(GO:0050982) |
| 0.0 | 0.7 | GO:0008089 | anterograde axonal transport(GO:0008089) |
| 0.0 | 0.3 | GO:0048243 | norepinephrine secretion(GO:0048243) |
| 0.0 | 1.4 | GO:1902400 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) signal transduction involved in mitotic G1 DNA damage checkpoint(GO:0072431) intracellular signal transduction involved in G1 DNA damage checkpoint(GO:1902400) |
| 0.0 | 0.1 | GO:2000628 | regulation of miRNA metabolic process(GO:2000628) |
| 0.0 | 0.2 | GO:0050957 | equilibrioception(GO:0050957) |
| 0.0 | 2.1 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
| 0.0 | 0.1 | GO:0061762 | CAMKK-AMPK signaling cascade(GO:0061762) |
| 0.0 | 0.3 | GO:0035729 | cellular response to hepatocyte growth factor stimulus(GO:0035729) |
| 0.0 | 0.2 | GO:0061088 | regulation of sequestering of zinc ion(GO:0061088) |
| 0.0 | 0.1 | GO:0042754 | negative regulation of circadian rhythm(GO:0042754) |
| 0.0 | 0.7 | GO:0016486 | peptide hormone processing(GO:0016486) |
| 0.0 | 0.4 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
| 0.0 | 1.6 | GO:0030516 | regulation of axon extension(GO:0030516) |
| 0.0 | 0.6 | GO:0032755 | positive regulation of interleukin-6 production(GO:0032755) |
| 0.0 | 0.2 | GO:0051601 | exocyst localization(GO:0051601) |
| 0.0 | 1.7 | GO:0001676 | long-chain fatty acid metabolic process(GO:0001676) |
| 0.0 | 0.5 | GO:0006040 | amino sugar metabolic process(GO:0006040) |
| 0.0 | 0.5 | GO:0061462 | protein localization to lysosome(GO:0061462) |
| 0.0 | 0.2 | GO:0007035 | vacuolar acidification(GO:0007035) |
| 0.0 | 0.4 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
| 0.0 | 0.4 | GO:0042116 | macrophage activation(GO:0042116) |
| 0.0 | 1.0 | GO:0010803 | regulation of tumor necrosis factor-mediated signaling pathway(GO:0010803) |
| 0.0 | 1.6 | GO:0051092 | positive regulation of NF-kappaB transcription factor activity(GO:0051092) |
| 0.0 | 1.3 | GO:0006939 | smooth muscle contraction(GO:0006939) |
| 0.0 | 0.0 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
| 0.0 | 0.5 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
| 0.0 | 0.1 | GO:0032292 | myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
| 0.0 | 0.2 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
| 0.0 | 0.4 | GO:0048536 | spleen development(GO:0048536) |
| 0.0 | 0.6 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
| 0.0 | 0.4 | GO:0071377 | cellular response to glucagon stimulus(GO:0071377) |
| 0.0 | 0.5 | GO:0043403 | skeletal muscle tissue regeneration(GO:0043403) |
| 0.0 | 0.7 | GO:0045540 | regulation of cholesterol biosynthetic process(GO:0045540) |
| 0.0 | 0.5 | GO:0007566 | embryo implantation(GO:0007566) |
| 0.0 | 0.3 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
| 0.0 | 0.6 | GO:0042267 | natural killer cell mediated cytotoxicity(GO:0042267) |
| 0.0 | 0.3 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
| 0.0 | 0.2 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
| 0.0 | 0.1 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
| 0.0 | 0.3 | GO:0097503 | sialylation(GO:0097503) |
| 0.0 | 0.3 | GO:0033006 | regulation of mast cell activation involved in immune response(GO:0033006) regulation of mast cell degranulation(GO:0043304) |
| 0.0 | 0.3 | GO:0003170 | heart valve development(GO:0003170) |
| 0.0 | 0.6 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
| 0.0 | 3.6 | GO:0050727 | regulation of inflammatory response(GO:0050727) |
| 0.0 | 0.1 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
| 0.0 | 0.6 | GO:0043392 | negative regulation of DNA binding(GO:0043392) |
Gene overrepresentation in cellular_component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.4 | 7.1 | GO:0009368 | endopeptidase Clp complex(GO:0009368) |
| 0.9 | 2.7 | GO:0000939 | condensed chromosome inner kinetochore(GO:0000939) |
| 0.9 | 2.7 | GO:0005607 | laminin-2 complex(GO:0005607) |
| 0.9 | 3.5 | GO:0005889 | hydrogen:potassium-exchanging ATPase complex(GO:0005889) |
| 0.9 | 2.6 | GO:0031523 | Myb complex(GO:0031523) |
| 0.7 | 8.9 | GO:0005642 | annulate lamellae(GO:0005642) |
| 0.7 | 3.0 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
| 0.7 | 4.4 | GO:0070435 | Shc-EGFR complex(GO:0070435) |
| 0.5 | 1.9 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
| 0.5 | 1.4 | GO:1990032 | parallel fiber(GO:1990032) |
| 0.4 | 3.6 | GO:0071144 | SMAD2-SMAD3 protein complex(GO:0071144) |
| 0.4 | 2.8 | GO:0043541 | UDP-N-acetylglucosamine transferase complex(GO:0043541) |
| 0.4 | 5.3 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
| 0.3 | 3.1 | GO:0016012 | sarcoglycan complex(GO:0016012) |
| 0.3 | 0.9 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
| 0.3 | 1.2 | GO:0045160 | myosin I complex(GO:0045160) |
| 0.3 | 2.3 | GO:0035976 | AP1 complex(GO:0035976) |
| 0.3 | 0.8 | GO:0031379 | RNA-directed RNA polymerase complex(GO:0031379) |
| 0.3 | 1.5 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
| 0.2 | 1.0 | GO:0043293 | apoptosome(GO:0043293) |
| 0.2 | 1.0 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
| 0.2 | 0.9 | GO:0033186 | CAF-1 complex(GO:0033186) |
| 0.2 | 0.7 | GO:0071748 | IgA immunoglobulin complex(GO:0071745) IgA immunoglobulin complex, circulating(GO:0071746) monomeric IgA immunoglobulin complex(GO:0071748) polymeric IgA immunoglobulin complex(GO:0071749) secretory IgA immunoglobulin complex(GO:0071751) |
| 0.2 | 4.2 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
| 0.2 | 3.6 | GO:0031209 | SCAR complex(GO:0031209) |
| 0.2 | 0.7 | GO:0071159 | NF-kappaB complex(GO:0071159) |
| 0.2 | 1.5 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
| 0.2 | 2.3 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
| 0.2 | 2.9 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
| 0.2 | 3.2 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
| 0.2 | 1.0 | GO:0097125 | cyclin B1-CDK1 complex(GO:0097125) |
| 0.2 | 2.5 | GO:0016600 | flotillin complex(GO:0016600) |
| 0.2 | 4.1 | GO:0030122 | AP-2 adaptor complex(GO:0030122) endolysosome membrane(GO:0036020) |
| 0.2 | 2.3 | GO:0032039 | integrator complex(GO:0032039) |
| 0.2 | 3.5 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
| 0.1 | 2.5 | GO:0000800 | lateral element(GO:0000800) |
| 0.1 | 1.1 | GO:0005587 | collagen type IV trimer(GO:0005587) |
| 0.1 | 1.7 | GO:0097433 | dense body(GO:0097433) |
| 0.1 | 0.7 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
| 0.1 | 1.2 | GO:0000796 | condensin complex(GO:0000796) |
| 0.1 | 0.6 | GO:1990769 | proximal neuron projection(GO:1990769) |
| 0.1 | 1.1 | GO:0030868 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
| 0.1 | 3.9 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
| 0.1 | 0.7 | GO:1902560 | GMP reductase complex(GO:1902560) |
| 0.1 | 1.4 | GO:0072687 | meiotic spindle(GO:0072687) |
| 0.1 | 1.7 | GO:0005869 | dynactin complex(GO:0005869) |
| 0.1 | 1.0 | GO:0098845 | postsynaptic endosome(GO:0098845) |
| 0.1 | 3.5 | GO:0097381 | photoreceptor disc membrane(GO:0097381) |
| 0.1 | 2.3 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
| 0.1 | 2.5 | GO:0030658 | transport vesicle membrane(GO:0030658) |
| 0.1 | 6.0 | GO:0001772 | immunological synapse(GO:0001772) |
| 0.1 | 0.9 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
| 0.1 | 0.3 | GO:0005588 | collagen type V trimer(GO:0005588) |
| 0.1 | 0.8 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
| 0.1 | 1.3 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
| 0.1 | 0.9 | GO:0042587 | glycogen granule(GO:0042587) |
| 0.1 | 0.3 | GO:0097443 | sorting endosome(GO:0097443) |
| 0.1 | 7.1 | GO:0045095 | keratin filament(GO:0045095) |
| 0.1 | 1.2 | GO:0000813 | ESCRT I complex(GO:0000813) |
| 0.1 | 0.9 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
| 0.1 | 0.6 | GO:0014802 | terminal cisterna(GO:0014802) |
| 0.1 | 2.9 | GO:0005719 | nuclear euchromatin(GO:0005719) |
| 0.1 | 0.6 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
| 0.1 | 1.3 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
| 0.1 | 0.9 | GO:0042788 | polysomal ribosome(GO:0042788) |
| 0.1 | 0.8 | GO:0001673 | male germ cell nucleus(GO:0001673) |
| 0.1 | 2.5 | GO:0005763 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
| 0.1 | 0.9 | GO:0061700 | GATOR2 complex(GO:0061700) |
| 0.1 | 1.9 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
| 0.1 | 1.1 | GO:0042555 | MCM complex(GO:0042555) |
| 0.1 | 0.5 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
| 0.1 | 0.6 | GO:0071986 | Ragulator complex(GO:0071986) |
| 0.1 | 1.0 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
| 0.1 | 5.6 | GO:1904724 | tertiary granule lumen(GO:1904724) |
| 0.1 | 1.8 | GO:0000795 | synaptonemal complex(GO:0000795) |
| 0.1 | 0.5 | GO:0005638 | lamin filament(GO:0005638) |
| 0.1 | 1.1 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
| 0.1 | 0.5 | GO:0016589 | NURF complex(GO:0016589) |
| 0.1 | 0.6 | GO:0044327 | dendritic spine head(GO:0044327) |
| 0.1 | 1.2 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
| 0.1 | 6.1 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
| 0.1 | 0.6 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
| 0.1 | 0.7 | GO:0017119 | Golgi transport complex(GO:0017119) |
| 0.1 | 1.5 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
| 0.0 | 1.1 | GO:0097225 | sperm midpiece(GO:0097225) |
| 0.0 | 0.7 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
| 0.0 | 3.9 | GO:0034707 | chloride channel complex(GO:0034707) |
| 0.0 | 0.5 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
| 0.0 | 5.7 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
| 0.0 | 0.7 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
| 0.0 | 6.3 | GO:0043202 | lysosomal lumen(GO:0043202) |
| 0.0 | 1.1 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
| 0.0 | 6.2 | GO:0031985 | Golgi cisterna(GO:0031985) |
| 0.0 | 16.6 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
| 0.0 | 1.3 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
| 0.0 | 2.6 | GO:0016235 | aggresome(GO:0016235) |
| 0.0 | 1.1 | GO:0031105 | septin complex(GO:0031105) |
| 0.0 | 0.6 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
| 0.0 | 0.6 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
| 0.0 | 0.3 | GO:1990452 | Parkin-FBXW7-Cul1 ubiquitin ligase complex(GO:1990452) |
| 0.0 | 1.7 | GO:0097610 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
| 0.0 | 0.3 | GO:0031415 | NatA complex(GO:0031415) |
| 0.0 | 1.9 | GO:0032420 | stereocilium(GO:0032420) |
| 0.0 | 0.5 | GO:0031526 | brush border membrane(GO:0031526) |
| 0.0 | 0.4 | GO:0001739 | sex chromatin(GO:0001739) |
| 0.0 | 3.1 | GO:0005902 | microvillus(GO:0005902) |
| 0.0 | 23.5 | GO:0005925 | focal adhesion(GO:0005925) |
| 0.0 | 1.0 | GO:0033202 | Ino80 complex(GO:0031011) DNA helicase complex(GO:0033202) |
| 0.0 | 0.8 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
| 0.0 | 3.6 | GO:0070821 | tertiary granule membrane(GO:0070821) |
| 0.0 | 1.3 | GO:0005795 | Golgi stack(GO:0005795) |
| 0.0 | 1.3 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
| 0.0 | 5.1 | GO:0031901 | early endosome membrane(GO:0031901) |
| 0.0 | 0.6 | GO:0030127 | COPII vesicle coat(GO:0030127) |
| 0.0 | 0.8 | GO:0090545 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
| 0.0 | 0.5 | GO:0005720 | nuclear heterochromatin(GO:0005720) |
| 0.0 | 0.8 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
| 0.0 | 0.4 | GO:0042589 | zymogen granule membrane(GO:0042589) |
| 0.0 | 0.4 | GO:0033391 | chromatoid body(GO:0033391) |
| 0.0 | 0.3 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
| 0.0 | 2.0 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
| 0.0 | 4.9 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
| 0.0 | 10.3 | GO:0005819 | spindle(GO:0005819) |
| 0.0 | 0.5 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
| 0.0 | 1.2 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
| 0.0 | 1.2 | GO:0005871 | kinesin complex(GO:0005871) |
| 0.0 | 0.3 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
| 0.0 | 1.4 | GO:0005581 | collagen trimer(GO:0005581) |
| 0.0 | 1.7 | GO:0005811 | lipid particle(GO:0005811) |
| 0.0 | 0.4 | GO:0099738 | cell cortex region(GO:0099738) |
| 0.0 | 1.6 | GO:0036064 | ciliary basal body(GO:0036064) |
| 0.0 | 1.0 | GO:0005905 | clathrin-coated pit(GO:0005905) |
| 0.0 | 0.6 | GO:0005859 | muscle myosin complex(GO:0005859) |
| 0.0 | 0.8 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
| 0.0 | 0.1 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
| 0.0 | 1.3 | GO:0030133 | transport vesicle(GO:0030133) |
| 0.0 | 0.3 | GO:0031083 | BLOC-1 complex(GO:0031083) |
| 0.0 | 1.1 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
| 0.0 | 3.6 | GO:0045121 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
| 0.0 | 1.2 | GO:0005856 | cytoskeleton(GO:0005856) |
| 0.0 | 0.4 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
| 0.0 | 1.0 | GO:0031970 | organelle envelope lumen(GO:0031970) |
| 0.0 | 0.7 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
| 0.0 | 0.9 | GO:0000313 | organellar ribosome(GO:0000313) mitochondrial ribosome(GO:0005761) |
| 0.0 | 0.4 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
| 0.0 | 1.9 | GO:0098791 | Golgi subcompartment(GO:0098791) |
| 0.0 | 0.5 | GO:0005604 | basement membrane(GO:0005604) |
| 0.0 | 0.9 | GO:0099501 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
| 0.0 | 0.3 | GO:0035580 | specific granule lumen(GO:0035580) |
| 0.0 | 0.5 | GO:0005844 | polysome(GO:0005844) |
Gene overrepresentation in molecular_function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.8 | 5.3 | GO:0070320 | inward rectifier potassium channel inhibitor activity(GO:0070320) |
| 1.7 | 5.0 | GO:0015130 | mevalonate transmembrane transporter activity(GO:0015130) |
| 1.4 | 5.6 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
| 1.0 | 5.7 | GO:0016314 | phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity(GO:0016314) |
| 0.8 | 4.9 | GO:0043183 | vascular endothelial growth factor receptor 1 binding(GO:0043183) |
| 0.7 | 3.6 | GO:0031962 | mineralocorticoid receptor binding(GO:0031962) |
| 0.7 | 2.8 | GO:0050509 | N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity(GO:0050509) |
| 0.6 | 4.4 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
| 0.6 | 1.8 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
| 0.6 | 11.3 | GO:0017070 | U6 snRNA binding(GO:0017070) |
| 0.6 | 2.3 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
| 0.6 | 2.3 | GO:0034602 | oxoglutarate dehydrogenase (NAD+) activity(GO:0034602) |
| 0.6 | 2.8 | GO:0070576 | vitamin D 24-hydroxylase activity(GO:0070576) |
| 0.6 | 3.9 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) procollagen-proline dioxygenase activity(GO:0019798) |
| 0.6 | 2.8 | GO:0001010 | transcription factor activity, sequence-specific DNA binding transcription factor recruiting(GO:0001010) |
| 0.6 | 1.7 | GO:0008518 | reduced folate carrier activity(GO:0008518) |
| 0.5 | 4.4 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
| 0.5 | 5.3 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
| 0.5 | 2.1 | GO:0004874 | aryl hydrocarbon receptor activity(GO:0004874) |
| 0.5 | 1.5 | GO:0051499 | D-aminoacyl-tRNA deacylase activity(GO:0051499) D-tyrosyl-tRNA(Tyr) deacylase activity(GO:0051500) |
| 0.5 | 1.4 | GO:0050254 | rhodopsin kinase activity(GO:0050254) |
| 0.5 | 1.4 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
| 0.4 | 1.3 | GO:0004609 | phosphatidylserine decarboxylase activity(GO:0004609) |
| 0.4 | 1.2 | GO:0070984 | SET domain binding(GO:0070984) |
| 0.4 | 3.2 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
| 0.4 | 2.4 | GO:0034046 | poly(G) binding(GO:0034046) |
| 0.4 | 3.5 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
| 0.4 | 1.9 | GO:0005152 | interleukin-1 receptor antagonist activity(GO:0005152) |
| 0.4 | 1.5 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
| 0.4 | 4.1 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
| 0.3 | 1.0 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
| 0.3 | 1.3 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
| 0.3 | 3.3 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
| 0.3 | 2.9 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
| 0.3 | 3.4 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
| 0.3 | 1.1 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
| 0.3 | 0.8 | GO:0031877 | somatostatin receptor binding(GO:0031877) |
| 0.3 | 8.2 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
| 0.3 | 2.8 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
| 0.3 | 1.5 | GO:0070137 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
| 0.2 | 0.7 | GO:0004608 | phosphatidyl-N-methylethanolamine N-methyltransferase activity(GO:0000773) phosphatidylethanolamine N-methyltransferase activity(GO:0004608) phosphatidyl-N-dimethylethanolamine N-methyltransferase activity(GO:0080101) |
| 0.2 | 2.1 | GO:1901612 | cardiolipin binding(GO:1901612) |
| 0.2 | 1.4 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
| 0.2 | 0.9 | GO:0033981 | D-dopachrome decarboxylase activity(GO:0033981) |
| 0.2 | 2.6 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
| 0.2 | 0.7 | GO:0036009 | protein-glutamine N-methyltransferase activity(GO:0036009) histone-glutamine methyltransferase activity(GO:1990259) |
| 0.2 | 5.4 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
| 0.2 | 2.1 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
| 0.2 | 1.7 | GO:0019158 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
| 0.2 | 2.9 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
| 0.2 | 0.8 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
| 0.2 | 0.6 | GO:0086062 | voltage-gated sodium channel activity involved in Purkinje myocyte action potential(GO:0086062) |
| 0.2 | 0.8 | GO:0005477 | pyruvate secondary active transmembrane transporter activity(GO:0005477) |
| 0.2 | 1.8 | GO:0032051 | clathrin light chain binding(GO:0032051) |
| 0.2 | 4.1 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
| 0.2 | 1.3 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
| 0.2 | 2.6 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
| 0.2 | 1.1 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
| 0.2 | 3.2 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
| 0.2 | 0.6 | GO:0072510 | ferric iron transmembrane transporter activity(GO:0015091) trivalent inorganic cation transmembrane transporter activity(GO:0072510) |
| 0.2 | 0.5 | GO:0004370 | glycerol kinase activity(GO:0004370) |
| 0.2 | 0.9 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
| 0.2 | 3.3 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
| 0.2 | 1.3 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
| 0.2 | 1.8 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
| 0.2 | 1.8 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
| 0.2 | 4.2 | GO:0017160 | Ral GTPase binding(GO:0017160) |
| 0.2 | 1.9 | GO:0048019 | receptor antagonist activity(GO:0048019) |
| 0.2 | 0.9 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
| 0.1 | 1.8 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
| 0.1 | 1.3 | GO:0045159 | myosin II binding(GO:0045159) |
| 0.1 | 2.5 | GO:0032052 | bile acid binding(GO:0032052) |
| 0.1 | 6.8 | GO:0070412 | R-SMAD binding(GO:0070412) |
| 0.1 | 0.7 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
| 0.1 | 1.1 | GO:0060072 | large conductance calcium-activated potassium channel activity(GO:0060072) |
| 0.1 | 1.1 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
| 0.1 | 2.1 | GO:0048185 | activin binding(GO:0048185) |
| 0.1 | 0.8 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
| 0.1 | 0.4 | GO:0005298 | proline:sodium symporter activity(GO:0005298) |
| 0.1 | 2.2 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
| 0.1 | 3.7 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
| 0.1 | 4.4 | GO:0015002 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
| 0.1 | 0.6 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
| 0.1 | 1.5 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
| 0.1 | 0.7 | GO:0016657 | GMP reductase activity(GO:0003920) oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor(GO:0016657) |
| 0.1 | 1.0 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
| 0.1 | 2.1 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
| 0.1 | 1.2 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
| 0.1 | 1.0 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
| 0.1 | 2.1 | GO:0004065 | arylsulfatase activity(GO:0004065) |
| 0.1 | 1.0 | GO:0050692 | DBD domain binding(GO:0050692) |
| 0.1 | 0.4 | GO:0016936 | galactoside binding(GO:0016936) |
| 0.1 | 0.5 | GO:0032450 | maltose alpha-glucosidase activity(GO:0032450) |
| 0.1 | 1.9 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
| 0.1 | 0.4 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
| 0.1 | 0.7 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
| 0.1 | 0.3 | GO:0036361 | racemase and epimerase activity, acting on amino acids and derivatives(GO:0016855) racemase activity, acting on amino acids and derivatives(GO:0036361) amino-acid racemase activity(GO:0047661) |
| 0.1 | 3.2 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
| 0.1 | 2.6 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
| 0.1 | 1.0 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
| 0.1 | 1.1 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
| 0.1 | 0.3 | GO:0004492 | methylmalonyl-CoA decarboxylase activity(GO:0004492) |
| 0.1 | 0.3 | GO:0043398 | HLH domain binding(GO:0043398) |
| 0.1 | 1.0 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
| 0.1 | 2.5 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
| 0.1 | 0.4 | GO:0004991 | parathyroid hormone receptor activity(GO:0004991) |
| 0.1 | 0.3 | GO:0003989 | acetyl-CoA carboxylase activity(GO:0003989) |
| 0.1 | 2.0 | GO:0017166 | vinculin binding(GO:0017166) |
| 0.1 | 2.9 | GO:0030552 | cAMP binding(GO:0030552) |
| 0.1 | 2.0 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
| 0.1 | 1.5 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
| 0.1 | 0.5 | GO:0015184 | L-cystine transmembrane transporter activity(GO:0015184) |
| 0.1 | 0.2 | GO:0098640 | integrin binding involved in cell-matrix adhesion(GO:0098640) |
| 0.1 | 2.7 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
| 0.1 | 0.8 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
| 0.1 | 1.3 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
| 0.1 | 1.4 | GO:0050700 | CARD domain binding(GO:0050700) |
| 0.1 | 1.4 | GO:0097602 | cullin family protein binding(GO:0097602) |
| 0.1 | 0.2 | GO:0052870 | tocopherol omega-hydroxylase activity(GO:0052870) alpha-tocopherol omega-hydroxylase activity(GO:0052871) 20-hydroxy-leukotriene B4 omega oxidase activity(GO:0097258) 20-aldehyde-leukotriene B4 20-monooxygenase activity(GO:0097259) |
| 0.1 | 0.5 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
| 0.1 | 0.5 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
| 0.1 | 0.2 | GO:0047783 | steroid 11-beta-monooxygenase activity(GO:0004507) corticosterone 18-monooxygenase activity(GO:0047783) |
| 0.1 | 0.9 | GO:0008296 | 3'-5'-exodeoxyribonuclease activity(GO:0008296) |
| 0.1 | 1.5 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
| 0.1 | 1.2 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
| 0.1 | 1.0 | GO:0035173 | histone kinase activity(GO:0035173) |
| 0.1 | 0.3 | GO:0032558 | adenyl deoxyribonucleotide binding(GO:0032558) dATP binding(GO:0032564) |
| 0.1 | 0.6 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
| 0.1 | 0.3 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
| 0.1 | 2.7 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
| 0.1 | 0.7 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
| 0.1 | 0.7 | GO:0003680 | AT DNA binding(GO:0003680) |
| 0.1 | 0.6 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
| 0.0 | 0.2 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
| 0.0 | 0.7 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
| 0.0 | 0.6 | GO:0015166 | polyol transmembrane transporter activity(GO:0015166) |
| 0.0 | 0.3 | GO:0004473 | malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) malate dehydrogenase (decarboxylating) (NADP+) activity(GO:0004473) |
| 0.0 | 0.5 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
| 0.0 | 0.9 | GO:0034185 | apolipoprotein binding(GO:0034185) |
| 0.0 | 0.5 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
| 0.0 | 2.3 | GO:0050699 | WW domain binding(GO:0050699) |
| 0.0 | 0.4 | GO:0001849 | complement component C1q binding(GO:0001849) |
| 0.0 | 1.1 | GO:0043495 | protein anchor(GO:0043495) |
| 0.0 | 0.3 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
| 0.0 | 1.5 | GO:0016866 | intramolecular transferase activity(GO:0016866) |
| 0.0 | 0.3 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
| 0.0 | 13.4 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
| 0.0 | 2.6 | GO:0048365 | Rac GTPase binding(GO:0048365) |
| 0.0 | 0.4 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
| 0.0 | 2.0 | GO:0030507 | spectrin binding(GO:0030507) |
| 0.0 | 6.7 | GO:0002020 | protease binding(GO:0002020) |
| 0.0 | 0.5 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
| 0.0 | 4.2 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
| 0.0 | 0.5 | GO:0016301 | kinase activity(GO:0016301) |
| 0.0 | 0.3 | GO:0050816 | phosphothreonine binding(GO:0050816) |
| 0.0 | 0.2 | GO:0031728 | CCR3 chemokine receptor binding(GO:0031728) |
| 0.0 | 3.2 | GO:0008307 | structural constituent of muscle(GO:0008307) |
| 0.0 | 0.6 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
| 0.0 | 0.5 | GO:0031996 | thioesterase binding(GO:0031996) |
| 0.0 | 0.4 | GO:0008432 | JUN kinase binding(GO:0008432) |
| 0.0 | 0.1 | GO:0001224 | RNA polymerase II transcription cofactor binding(GO:0001224) |
| 0.0 | 0.3 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
| 0.0 | 0.6 | GO:0004180 | carboxypeptidase activity(GO:0004180) |
| 0.0 | 0.8 | GO:0022848 | acetylcholine-gated cation channel activity(GO:0022848) |
| 0.0 | 1.0 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
| 0.0 | 15.0 | GO:0005525 | GTP binding(GO:0005525) |
| 0.0 | 0.6 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
| 0.0 | 2.6 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
| 0.0 | 0.3 | GO:0086007 | voltage-gated calcium channel activity involved in cardiac muscle cell action potential(GO:0086007) |
| 0.0 | 1.9 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
| 0.0 | 0.2 | GO:0050733 | RS domain binding(GO:0050733) |
| 0.0 | 0.9 | GO:0000217 | DNA secondary structure binding(GO:0000217) |
| 0.0 | 10.7 | GO:0005096 | GTPase activator activity(GO:0005096) |
| 0.0 | 0.8 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
| 0.0 | 0.2 | GO:0032396 | inhibitory MHC class I receptor activity(GO:0032396) |
| 0.0 | 3.5 | GO:0044325 | ion channel binding(GO:0044325) |
| 0.0 | 0.8 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
| 0.0 | 0.1 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
| 0.0 | 1.8 | GO:0030276 | clathrin binding(GO:0030276) |
| 0.0 | 0.8 | GO:0045503 | dynein light chain binding(GO:0045503) |
| 0.0 | 0.1 | GO:0043559 | insulin binding(GO:0043559) |
| 0.0 | 3.0 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
| 0.0 | 1.1 | GO:0061650 | ubiquitin conjugating enzyme activity(GO:0061631) ubiquitin-like protein conjugating enzyme activity(GO:0061650) |
| 0.0 | 0.8 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
| 0.0 | 0.5 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
| 0.0 | 0.7 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
| 0.0 | 0.8 | GO:0005484 | SNAP receptor activity(GO:0005484) |
| 0.0 | 0.1 | GO:0001042 | RNA polymerase I core binding(GO:0001042) |
| 0.0 | 0.1 | GO:0008121 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
| 0.0 | 3.1 | GO:0030674 | protein binding, bridging(GO:0030674) |
| 0.0 | 0.1 | GO:0003963 | RNA-3'-phosphate cyclase activity(GO:0003963) |
| 0.0 | 1.9 | GO:0005179 | hormone activity(GO:0005179) |
| 0.0 | 0.6 | GO:0008066 | glutamate receptor activity(GO:0008066) |
| 0.0 | 0.3 | GO:0046332 | SMAD binding(GO:0046332) |
| 0.0 | 0.1 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
| 0.0 | 0.2 | GO:0048156 | tau protein binding(GO:0048156) |
| 0.0 | 0.4 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
| 0.0 | 1.0 | GO:0020037 | heme binding(GO:0020037) |
| 0.0 | 0.7 | GO:0004536 | deoxyribonuclease activity(GO:0004536) |
| 0.0 | 0.2 | GO:0071837 | HMG box domain binding(GO:0071837) |
| 0.0 | 0.2 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
| 0.0 | 0.1 | GO:1904047 | S-adenosyl-L-methionine binding(GO:1904047) |
| 0.0 | 1.1 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
| 0.0 | 0.7 | GO:0003678 | DNA helicase activity(GO:0003678) |
| 0.0 | 1.4 | GO:0047485 | protein N-terminus binding(GO:0047485) |
| 0.0 | 0.2 | GO:0003924 | GTPase activity(GO:0003924) |
| 0.0 | 0.2 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
| 0.0 | 0.2 | GO:0003993 | acid phosphatase activity(GO:0003993) |
| 0.0 | 1.1 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
Gene overrepresentation in C2:CP category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.3 | 14.6 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
| 0.3 | 4.9 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
| 0.2 | 5.7 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
| 0.2 | 1.7 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
| 0.2 | 5.3 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
| 0.1 | 2.5 | PID RAC1 PATHWAY | RAC1 signaling pathway |
| 0.1 | 2.7 | ST G ALPHA S PATHWAY | G alpha s Pathway |
| 0.1 | 3.7 | PID CONE PATHWAY | Visual signal transduction: Cones |
| 0.1 | 2.7 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
| 0.1 | 3.0 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
| 0.1 | 3.2 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
| 0.1 | 3.6 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
| 0.1 | 3.9 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
| 0.1 | 1.0 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
| 0.1 | 1.1 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
| 0.1 | 1.9 | ST GAQ PATHWAY | G alpha q Pathway |
| 0.1 | 3.8 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
| 0.1 | 0.7 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
| 0.1 | 4.4 | PID AURORA A PATHWAY | Aurora A signaling |
| 0.1 | 2.6 | ST G ALPHA I PATHWAY | G alpha i Pathway |
| 0.1 | 2.7 | PID NECTIN PATHWAY | Nectin adhesion pathway |
| 0.1 | 1.5 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
| 0.1 | 2.3 | PID EPHB FWD PATHWAY | EPHB forward signaling |
| 0.1 | 1.1 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
| 0.1 | 1.7 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
| 0.1 | 1.5 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
| 0.1 | 2.1 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
| 0.0 | 2.6 | PID ATR PATHWAY | ATR signaling pathway |
| 0.0 | 1.0 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
| 0.0 | 2.4 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
| 0.0 | 0.9 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
| 0.0 | 1.5 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
| 0.0 | 0.9 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
| 0.0 | 13.6 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
| 0.0 | 0.9 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
| 0.0 | 1.5 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
| 0.0 | 2.1 | PID AURORA B PATHWAY | Aurora B signaling |
| 0.0 | 1.7 | PID TNF PATHWAY | TNF receptor signaling pathway |
| 0.0 | 4.1 | PID E2F PATHWAY | E2F transcription factor network |
| 0.0 | 1.1 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
| 0.0 | 1.4 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
| 0.0 | 0.8 | PID FGF PATHWAY | FGF signaling pathway |
| 0.0 | 2.0 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
| 0.0 | 1.9 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
| 0.0 | 0.6 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
| 0.0 | 1.0 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
| 0.0 | 1.1 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
| 0.0 | 1.9 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
| 0.0 | 1.5 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
| 0.0 | 0.5 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
| 0.0 | 0.3 | PID IFNG PATHWAY | IFN-gamma pathway |
| 0.0 | 0.4 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
| 0.0 | 0.4 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
| 0.0 | 0.3 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
| 0.0 | 0.5 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
| 0.0 | 0.5 | PID BCR 5PATHWAY | BCR signaling pathway |
| 0.0 | 1.3 | PID P73PATHWAY | p73 transcription factor network |
| 0.0 | 0.3 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
| 0.0 | 0.2 | PID IL5 PATHWAY | IL5-mediated signaling events |
| 0.0 | 0.3 | PID MYC PATHWAY | C-MYC pathway |
| 0.0 | 0.3 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
| 0.0 | 0.2 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
| 0.0 | 0.4 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
Gene overrepresentation in C2:CP:REACTOME category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.3 | 5.8 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
| 0.3 | 7.1 | REACTOME SHC MEDIATED SIGNALLING | Genes involved in SHC-mediated signalling |
| 0.3 | 9.8 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
| 0.3 | 11.5 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
| 0.3 | 3.9 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
| 0.3 | 10.5 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
| 0.2 | 6.5 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
| 0.2 | 5.6 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
| 0.2 | 4.9 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
| 0.2 | 4.1 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
| 0.2 | 1.7 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
| 0.2 | 3.1 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
| 0.2 | 2.7 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
| 0.2 | 2.8 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
| 0.1 | 2.0 | REACTOME OPSINS | Genes involved in Opsins |
| 0.1 | 2.8 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
| 0.1 | 1.8 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
| 0.1 | 4.9 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
| 0.1 | 2.4 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
| 0.1 | 4.5 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
| 0.1 | 2.3 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
| 0.1 | 3.7 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
| 0.1 | 3.3 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
| 0.1 | 2.3 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
| 0.1 | 1.4 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
| 0.1 | 2.4 | REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB | Genes involved in PKA-mediated phosphorylation of CREB |
| 0.1 | 1.0 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
| 0.1 | 1.2 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
| 0.1 | 2.1 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
| 0.1 | 1.5 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
| 0.1 | 2.4 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
| 0.1 | 1.8 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
| 0.1 | 3.0 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
| 0.1 | 2.3 | REACTOME CELL CELL JUNCTION ORGANIZATION | Genes involved in Cell-cell junction organization |
| 0.1 | 2.3 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
| 0.1 | 1.1 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
| 0.1 | 1.8 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
| 0.1 | 0.9 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
| 0.1 | 1.0 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
| 0.1 | 0.3 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
| 0.1 | 1.6 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
| 0.0 | 1.7 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
| 0.0 | 4.7 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
| 0.0 | 1.9 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
| 0.0 | 0.5 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
| 0.0 | 2.1 | REACTOME REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN | Genes involved in Regulation of Glucokinase by Glucokinase Regulatory Protein |
| 0.0 | 0.5 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
| 0.0 | 0.5 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
| 0.0 | 0.9 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
| 0.0 | 1.1 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
| 0.0 | 5.0 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
| 0.0 | 0.8 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
| 0.0 | 1.5 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
| 0.0 | 0.8 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
| 0.0 | 0.6 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
| 0.0 | 1.5 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
| 0.0 | 0.7 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
| 0.0 | 4.1 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
| 0.0 | 1.4 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
| 0.0 | 1.2 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
| 0.0 | 0.6 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII | Genes involved in CREB phosphorylation through the activation of CaMKII |
| 0.0 | 1.8 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
| 0.0 | 2.5 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
| 0.0 | 2.0 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
| 0.0 | 1.3 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
| 0.0 | 0.8 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
| 0.0 | 0.7 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
| 0.0 | 1.0 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
| 0.0 | 1.0 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
| 0.0 | 2.4 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
| 0.0 | 1.1 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
| 0.0 | 2.0 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
| 0.0 | 1.5 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
| 0.0 | 0.6 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF CYCLIN B | Genes involved in APC/C:Cdc20 mediated degradation of Cyclin B |
| 0.0 | 0.6 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
| 0.0 | 0.1 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
| 0.0 | 0.9 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
| 0.0 | 0.6 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
| 0.0 | 0.7 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
| 0.0 | 0.5 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
| 0.0 | 0.4 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
| 0.0 | 0.4 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
| 0.0 | 0.6 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
| 0.0 | 0.3 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
| 0.0 | 0.2 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
| 0.0 | 0.4 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
| 0.0 | 0.1 | REACTOME NUCLEAR EVENTS KINASE AND TRANSCRIPTION FACTOR ACTIVATION | Genes involved in Nuclear Events (kinase and transcription factor activation) |
| 0.0 | 0.4 | REACTOME MRNA SPLICING MINOR PATHWAY | Genes involved in mRNA Splicing - Minor Pathway |